爱博医疗前三季度净利2.9亿元，同比下降8.64%

Core Viewpoint - Aibo Medical (688050) reported a revenue of 1.144 billion yuan for the first three quarters of 2025, reflecting a year-on-year growth of 6.43%, while the net profit attributable to shareholders decreased by 8.64% to 290 million yuan [1] Financial Performance - The company's revenue for the first three quarters reached 1.144 billion yuan, marking a 6.43% increase compared to the same period last year [1] - The net profit attributable to shareholders was 290 million yuan, which represents a decline of 8.64% year-on-year [1] Revenue Drivers - The decline in profit is primarily attributed to a decrease in revenue from artificial lenses and contact lenses [1] - The company has increased its investment in promoting its own brand of contact lenses, which has also contributed to the profit decline [1]